Project Number ADDF-28 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2020 View Full Project Details for Clinical Validation of Accreditation for Plasma Abeta42/Abeta40 as a Biomarker for Alzheimer's Disease Pathology Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers b. Blood-based Biomarkers Researcher and Organization Principal Investigator Yarasheski, Kevin Principal Investigator Yarasheski, Kevin Awardee Organization C2N Diagnostics Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $2,225,237 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management
